SCL Science Balance Sheet Health
Financial Health criteria checks 3/6
SCL Science has a total shareholder equity of ₩18.3B and total debt of ₩7.7B, which brings its debt-to-equity ratio to 41.9%. Its total assets and total liabilities are ₩29.8B and ₩11.5B respectively.
Key information
41.9%
Debt to equity ratio
₩7.67b
Debt
Interest coverage ratio | n/a |
Cash | ₩5.93b |
Equity | ₩18.31b |
Total liabilities | ₩11.52b |
Total assets | ₩29.83b |
Financial Position Analysis
Short Term Liabilities: A246960's short term assets (₩8.8B) exceed its short term liabilities (₩3.6B).
Long Term Liabilities: A246960's short term assets (₩8.8B) exceed its long term liabilities (₩7.9B).
Debt to Equity History and Analysis
Debt Level: A246960's net debt to equity ratio (9.6%) is considered satisfactory.
Reducing Debt: A246960's debt to equity ratio has increased from 4.6% to 41.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A246960 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: A246960 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 11.4% each year